4.3 Article

GeneXpert® for smear-negative pulmonary tuberculosis: does it play a role in low-burden countries?

期刊

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2012.11.011

关键词

Early diagnosis; Mycobacterium tuberculosis; Nucleic acid amplification; Xpert MTB/RIF assay

向作者/读者索取更多资源

We performed a retrospective analysis of costs and time to treatment (TT) of 150 culture-confirmed TB cases: 100 sputum smear (SS) (+) and 50 SS(). This group underwent GeneXpert (R) (GX) assay. Expenditures and IT of SS(-)/GX(+) cases were inferred from the SS(+) group. GX detected 68% of SS(-) cases. (C) 2013 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据